$COLL 8-K/A SEC Filings

Filed On	Filing
30 Jun 2026	8-K/A: Financial Statements and Exhibits On May 12, 2026, Collegium Pharmaceutical, Inc. (the “Company” or “Collegium”) completed the previously announced acquisition (the “Closing”) of (i) all of the issued and outstanding limited liability interests of GPC Commave Holding, LL...
14 Nov 2024	8-K/A: Financial Statements and Exhibits Consolidated Statements of Operations and Comprehensive Loss
13 May 2022	8-K/A: Financial Statements and Exhibits

Comments